DJIA 17,804.80 26.65 0.15%
NASDAQ 4,765.38 16.98 0.36%
S&P 500 2,070.65 9.42 0.46%
market minute promo

Gilead Sciences (NASDAQ: GILD)

108.45 2.91 (2.76%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

GILD $108.45 2.76%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $105.89
Previous Close $105.54
Daily Range $104.64 - $109.49
52-Week Range $63.50 - $116.83
Market Cap $163.6B
P/E Ratio 18.71
Dividend (Yield) $0.00 (0.0%)
Volume 21,178,614
Average Daily Volume 15,189,235
Current FY EPS $7.91





Gilead Sciences (GILD) Description

Gilead Sciences created and sells the world’s top-selling HIV medications, Truvada and Atripla, and commands about 75% of the U.S. treatment market and more than 50% worldwide. Website:

News & Commentary Rss Feed

3 Pharma Giants Growing Significantly Faster Than Pfizer, Inc.

Pfizer is a staple in most retirement and income portfolios, but investors can find stronger growth prospects in each of these three big pharmaceutical stocks.

Gilead: What's Ahead In 2015 For This Biotech Juggernaut

While Gilead's Profits Soar, Uncertainty Reigns Supreme At AbbVie

United Therapeutics Lung Drug Keeps Going And Going

Abbvie's Hep C Regimen Approved, Marketing Battle With Gilead Up Next

Cramer: ‘Downside’ to Biotech as ImmunoGen Stock Cut in Half

The 2015 Calendar Of NASH Trial Catalysts IV: GENFIT And Gilead

Jim Cramer's 'Mad Money' Recap: 10 Reasons We'll Have a Santa Claus Rally

Alexion's Rare Disease Model Analyzed

Biogen Idec Poised To Continue Its Stellar Run

See More GILD News...

GILD's Top Competitors

GILD $108.45 (2.76%)
Current stock: GILD
AMGN $170.17 (1.00%)
Current stock: AMGN
CELG $117.18 (0.60%)
Current stock: CELG
$0.00 (0.00%)
Current stock: